CK Wang, MD, chief medical officer of COTA, discusses how real-world data help identify disparities and gaps in cancer care.

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

The START Hope Hub is a robust digital platform designed to break down barriers to early-phase clinical trial access for ...

New DNA test predicts chemotherapy resistance before treatment, potentially sparing patients from ineffective toxic drugs.

In a Cleveland Clinic cohort, patients who stopped treatment for obesity had smaller weight losses to start, making these ...

FDA approves tafasitamab with lenalidomide and rituximab, offering a groundbreaking chemotherapy-free treatment for relapsed ...

It’s been over two years since The Resident was canceled after six seasons on Fox, a decision that came months after the ...

In an exhibition at this year’s Belfast Photo Festival, Antón exhibits imagery based on real testimony from the 17th century ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

In a functioning system, the kind of placebo-controlled vaccine trials that Secretary Kennedy is calling for would never get past an IRB, much less progress to an IND application. Vaccines are being ...

In CNS research, where qualitative endpoint variability can significantly affect a trial’s outcome, the role of eCOA is ...

A tiny Aussie-made patch could be the secret weapon propelling our Olympic athletes to gold, while revolutionising a $100bn ...